HIF-1: An Oxygen Response System with Special Relevance to the Kidney
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Requirement of Cells for Oxygen All metazoan organisms are committed to respiration, using oxygen as the terminal electron acceptor in a reaction that is carried out by cytochrome c oxidase. The consequence is that cells need a continuous supply of oxygen. In higher organisms such as humans, an extensive infrastructure is required to achieve this. It includes the airways, lungs, heart, and vascular network, but the “organ” most clearly devoted to this task is the erythron—consisting of 2 × 1013 cells, occupying 2 L, and carrying 99% of the oxygen in the blood. The size of this circulating organ is regulated through the action of erythropoietin (EPO), which acts as a survival factor for red blood cell precursors. A fundamental challenge underlying much of the physiology and anatomy of higher organisms is avoiding local oxygen starvation. The efficiency with which we meet this challenge means that it easy to take it for granted. Adding to the precision that is required, excess oxygen is potentially dangerous, with the ability to generate reactive species that may damage proteins and nucleic acid. Hypoxia-inducible factor-1 (HIF-1) is a transcription complex that was isolated as a factor controlling EPO gene expression (1) and is now recognized to be centrally involved in many aspects of meeting these challenges. The HIF-1 system operates in all mammalian cell types examined to date but has specific relevance to the kidney in several ways. First, HIF-1 underlies regulation of EPO, and the kidney is the dominant site of production. Intriguing is that compromised EPO production is a striking feature of many kidney diseases; understanding why this is so could provide insight into the events that lead to continuing renal damage and clues as to how it could be prevented. Second, parts of the kidney experience low oxygen tensions even under normal circumstances (2), and the kidney is very sensitive to hypoperfusion injury (3). Third, constitutive activation of HIF-1 occurs in the great majority of clear cell renal cell carcinomas (CCRCC), which is the most common form of cancer affecting the kidney (4). This is because the von Hippel-Lindau (VHL) tumor suppressor gene has a critical role in the regulation of HIF-1 (5). Furthermore, inheriting a defective VHL gene results in a very high risk of CCRCC and does not predispose to cancer in other organs (6). This suggests that HIF-1 may have a very specific role in controlling the behavior of kidney epithelial cells. This review summarizes how the HIF-1 system works and what it does, with some emphasis on two areas that have been important in understanding how HIF-1 is regulated and are relevant to renal physiology and pathology. These are the control of EPO production and the effect of activation of HIF-1 in renal cells when the VHL tumor suppressor gene is inactivated. HIF-1 Oxygen Response System An HIF-1 complex contains an α and a β subunit. Both subunits are members of multiprotein families and belong to the extended family of basic helix-loop-helix PAS domain transcription factors (1). The β subunit is constitutively expressed, and HIF-1β is also known as the aryl hydrocarbon receptor nuclear translocator. This protein has an important role in responses to xenobiotics, where it forms a heterodimeric transcription complex with the aryl hydrocarbon receptor. The alternate α subunits of the HIF-1 complex, HIF-1α and HIF-2α, are regulated by oxygen and are unique to the oxygen response pathway. How HIF-1 Responds to Oxygen At the heart of the HIF-1 system, molecular oxygen reacts with HIF-α proteins in a way that switches their ability to interact with other proteins (Figure 1). The HIF-α chain is regulated by two enzymatic reactions in which molecular oxygen reacts with specific amino acid residues (7–9). The addition of a single 16-Da oxygen atom to a prolyl residue in the central region of these approximately 120 kD proteins leads to capture by the VHL tumor suppressor protein (7,8). In a second reaction, addition of a single oxygen atom to an asparaginyl residue near the C terminus of HIF-α chains prevents HIF-1 from interacting with the co-activator required to switch on target genes (9). Figure 1. : Regulation of hypoxia-inducible factor (HIF). At low levels of oxygen, HIF-α forms an active HIF-1 complex with a β subunit and recruits P300 (left). As the oxygen concentration increases, the rate of the reactions in the right panel increases. This inactivates HIF-α by hydroxylation of a prolyl residue in the oxygen-dependent destruction domain (Pro402 or 564 of HIF-1α) and an asparaginyl residue in the C terminal transcativation domain (Asn803 of HIF-1α). The prolyl modification is carried out by prolyl hydroxylase domain enzymes and enables capture by the von Hippel-Lindau (VHL) gene. The asparaginyl modification prevents the interaction with P300.Both of these reactions are catalyzed by 2-oxoglutarate–dependent dioxygenases, which belong to an extended family of
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The addition of a single 16-Da oxygen atom to a prolyl residue in the central region of these approximately 120 kD proteins leads to capture by the VHL tumor suppressor protein (7,8).”
BackgroundSelf-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“HIF-1 activation also influences decisions concerning cell proliferation and apoptosis (60,61).”
BackgroundSelf-citationCellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 1×
“Activation of HIF-1 in response to hypoxia results in increased expression of glucose transporters and glycolytic enzymes (27).”
BackgroundMutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550
Cited by
Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure
Nangaku, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070757 · Cited by 1,135
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Warnecke, C., Zaborowska, Z., Kurreck, J., Erdmann, V. A., Frei, U., Wiesener, M., & Eckardt, K. (2004) · The FASEB Journal · doi:10.1096/fj.04-1640fje · Cited by 398
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Albadari, N., Deng, S., & Li, W. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1613370 · Cited by 351
Preconditional Activation of Hypoxia-Inducible Factors Ameliorates Ischemic Acute Renal Failure
Bernhardt, W. M., Ca[Combining Circumflex Accent]mpean, V., Kany, S., Ju[Combining Diaeresis]rgensen, J.-S., Weidemann, A., Warnecke, C., Arend, M., Klaus, S., Gu[Combining Diaeresis]nzler, V., Amann, K., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121302 · Cited by 295
Metadata
- Authors
- Maxwell, P.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2003-11
- Volume
- 14
- Issue
- 11
- Pages
- 2712-2722
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2164945237
- Cited by
- 132
- References
- 41
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIF-1: An Oxygen Response System with Special Relevance to the Kidney. https://app.cochat.ai/papers/10.1097/01.asn.0000092792.97122.e0
- The paper
- Maxwell, P. (2003). HIF-1: An Oxygen Response System with Special Relevance to the Kidney. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000092792.97122.e0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.